AUTL · ISSUER CIK 1730463
Autolus Therapeutics plc
Between Aug 1, 2026 and Oct 29, 2026, 1 Autolus Therapeutics plc insiders reported $0.00 of open-market purchases and $16K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$16KInsider selling
−$16KNet open-market
Sep 3, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 202616:36 | Sep 2, 2026 | AUTL | U.S. CCO & Country Gen Manager | S · Sell | $2.34 | −6,713 | 13,287 | -34% | −$16K | ||
| Sep 3, 202616:36 | Sep 1, 2026 | AUTL | U.S. CCO & Country Gen Manager | M · Exercise | $2.35 | +20,000 | 20,000 | New | $47K |